News

Latest News | 2 May 2013

Public Citizen Blasts Draft Compounding Rules, Says New Category Would Skirt Regulatory Requirements

1 Likes

A US Senate proposal to overhaul the way in which compounded pharmaceutical products are regulated is being slammed by a prominent public advocacy group, Public Citizen, which claims that the proposed Read More...

---

Latest News | 20 March 2013

Delay in Sending Warning Letter to Fat Loss Device Company Hurt Patients, Group Claims

1 Likes

A new warning letter sent by the US Food and Drug Administration (FDA) to medical device manufacturer RevecoMED regarding the sale and use of its "LipoTRON 30000" device is bringing both praise and Read More...

---

Latest News | 5 October 2012

Group Calls for REMS-Like Conditions for Popular Hypertension Drugs

0 Likes

The public safety advocacy group Public Citizen is calling on the US Food and Drug Administration (FDA) to place additional safety warnings and restrictions on several classes of hypertension drugs Read More...

---

Latest News | 28 September 2012

Study: Regulatory Noncompliance Plays Big Role in Record-Setting Fines

1 Likes

Regulatory compliance woes have contributed to record-setting fines paid by pharmaceutical companies since 1991—more than $30 billion in total -- claims a new report published by the health advocacy Read More...

---

Latest News | 19 September 2012

Group: FDA's Interpretation of FOIA Procedures Illegal

0 Likes

The public health advocacy group Public Citizen is blasting the US Food and Drug Administration (FDA) for its application of the Freedom of Information Act (FOIA), saying in a statement that the Read More...

---

Latest News | 6 September 2012

Group Sues FDA, Seeking to Compel it to Withdraw Alzheimer's Drug from Market

0 Likes

Consumer advocacy group Public Citizen has filed a lawsuit against the US Food and Drug Administration (FDA) seeking to compel it to remove a particular dose of the Alzheimer's drug Aricept, which the Read More...

---

Latest News | 4 June 2012

Group Calls for Changes to User Fee Bill After Transparency Concerns Emerge

0 Likes

A group of 20 public interest organizations has written the US Congress to express their displeasure with a measure which would purportedly allow the US Food and Drug Administration (FDA) to hide Read More...

---

Latest News | 20 April 2012

Public Citizen to FDA: Diabetes Drug Unsafe, Should Be Pulled

0 Likes

The watchdog group Public Citizen is calling on the US Food and Drug Administration (FDA) to yank Novo Nordisk’s diabetes drug Victoza (liraglutide) off the market for safety risks it says “outweigh Read More...

---

Latest News | 1 March 2012

Consumers Groups Attack FDA Over De Novo Process

1 Likes

A group of 12 consumer groups is chastising the US Food and Drug Administration (FDA) for approving what they perceive to be ‘high-risk’ medical devices through FDA’s de novo approval pathway.In a Read More...

---